Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Open access
Moore, Katrina M, Nicholas, Jennifer, Grossman, Murray, McMillan, Corey T, Irwin, David J, Massimo, Lauren, Van Deerlin, Vivianna M, Warren, Jason D, Fox, Nick C, Rossor, Martin N, Mead, Simon, Bocchetta, Martina, Boeve, Bradley F, Knopman, David S, Graff-Radford, Neill R, Forsberg, Leah K, Rademakers, Rosa, Wszolek, Zbigniew K, van Swieten, John C, Jiskoot, Lize C, Meeter, Lieke H, Dopper, Elise GP, Papma, Janne M, Snowden, Julie S, Saxon, Jennifer, Jones, Matthew, Pickering-Brown, Stuart, Le Ber, Isabelle, Camuzat, Agnès, Brice, Alexis, Caroppo, Paola, Ghidoni, Roberta, Pievani, Michela, Benussi, Luisa, Binetti, Giuliano, Dickerson, Bradford C, Lucente, Diane, Krivensky, Samantha, Graff, Caroline, Öijerstedt, Linn, Fallström, Marie, Thonberg, Håkan, Ghoshal, Nupur, Morris, John C, Borroni, Barbara, Benussi, Alberto, Padovani, Alessandro, Galimberti, Daniela, Scarpini, Elio, Fumagalli, Giorgio G, Mackenzie, Ian R, Hsiung, Ging-Yuek R, Sengdy, Pheth, Boxer, Adam L, Rosen, Howie, Taylor, Joanne B, Synofzik, Matthis, Wilke, Carlo, Sulzer, Patricia, Hodges, John R, Halliday, Glenda, Kwok, John, Sanchez-Valle, Raquel, Lladó, Albert, Borrego-Ecija, Sergi, Santana, Isabel, Almeida, Maria Rosário, Tábuas-Pereira, Miguel, Moreno, Fermin, Barandiaran, Myriam, Indakoetxea, Begoña, Levin, Johannes, Danek, Adrian, Rowe, James B, Cope, Thomas E, Otto, Markus, Anderl-Straub, Sarah, de Mendonça, Alexandre, Maruta, Carolina, Masellis, Mario, Black, Sandra E, Couratier, Philippe, Lautrette, Geraldine, Huey, Edward D, Sorbi, Sandro, Nacmias, Benedetta, Laforce, Robert, Tremblay, Marie-Pier L, Vandenberghe, Rik, Damme, Philip Van, Rogalski, Emily J, Weintraub, Sandra, Gerhard, Alexander, Onyike, Chiadi U, Ducharme, Simon, Papageorgiou, Sokratis G, Ng, Adeline Su Lyn, Brodtmann, Amy, Finger, Elizabeth, Guerreiro, Rita, Bras, Jose, Rohrer, Jonathan D, Heller, Carolin, Convery, Rhian S, Woollacott, Ione OC, Shafei, Rachelle M, Graff-Radford, Jonathan, Jones, David T, Dheel, Christina M, Savica, Rodolfo, Lapid, Maria I, Baker, Matt, Fields, Julie A, Gavrilova, Ralitza, Domoto-Reilly, Kimiko, Poos, Jackie M, Van der Ende, Emma L, Panman, Jessica L, Donker Kaat, Laura, Seelaar, Harro, Richardson, Anna, Frisoni, Giovanni, Mega, Anna, Fostinelli, Silvia, Chiang, Huei-Hsin, Alberici, Antonella, Arighi, Andrea, Fenoglio, Chiara, Heuer, Hilary, Miller, Bruce, Karydas, Anna, Fong, Jamie, João Leitão, Maria, Santiago, Beatriz, Duro, Diana, Ferreira, Carlos, Gabilondo, Alazne, De Arriba, Maria, Tainta, Mikel, Zulaica, Miren, Ferreira, Catarina, Semler, Elisa, Ludolph, Albert, Landwehrmeyer, Bernhard, Volk, Alexander E, Miltenberger, Gabriel, Verdelho, Ana, Afonso, Sónia, Tartaglia, Maria Carmela, Freedman, Morris, Rogaeva, Ekaterina, Ferrari, Camilla, Piaceri, Irene, Bessi, Valentina, Lombardi, Gemma, St-Onge, Frédéric, Doré, Marie-Claire, Bruffaerts, Rose, Vandenbulcke, Mathieu, Van den Stock, Jan, Mesulam, M Marsel, Bigio, Eileen, Koros, Christos, Papatriantafyllou, John, Kroupis, Christos, Stefanis, Leonidas, Shoesmith, Christien, Robertson, Erik, Coppola, Giovanni, Da Silva Ramos, Eliana Marisa, Geschwind, Daniel · 2020 · The Lancet Neurology

Abstract

Background Frontotemporal dementia is a heterogenous neurodegenerative disorder, with about a third of cases being genetic. Most of this genetic component is accounted for by mutations in GRN, MAPT, and C9orf72. In this study, we aimed to complement previous phenotypic studies by doing an international study of age at symptom onset, age at death, and disease duration in individuals with mutations in GRN, MAPT, and C9orf72.Methods In this international, retrospective cohort study, we collected data on age at symptom onset, age at death, and disease duration for patients with pathogenic mutations in the GRN and MAPT genes and pathological expansions in the C9orf72 gene through the Frontotemporal Dementia Prevention Initiative and from published papers. We used mixed effects models to explore differences in age at onset, age at death, and disease duration between genetic groups and individual mutations. We also assessed correlations between the age at onset and at death of each individual and the age at onset and at death of their parents and the mean age at onset and at death of their family members. Lastly, we used mixed effects models to investigate the extent to which variability in age at onset and at death could be accounted for by family membership and the specific mutation carried.Findings Data were available from 3403 individuals from 1492 families: 1433 with C9orf72 expansions (755 families), 1179 with GRN mutations (483 families, 130 different mutations), and 791 with MAPT mutations (254 families, 67 different mutations). Mean age at symptom onset and at death was 49·5 years (SD 10·0; onset) and 58·5 years (11·3; death) in the MAPT group, 58·2 years (9·8; onset) and 65·3 years (10·9; death) in the C9orf72 group, and 61·3 years (8·8; onset) and 68·8 years (9·7; death) in the GRN group. Mean disease duration was 6·4 years (SD 4·9) in the C9orf72 group, 7·1 years (3·9) in the GRN group, and 9·3 years (6·4) in the MAPT group. Individual age at onset and at death was significantly correlated with both parental age at onset and at death and with mean family age at onset and at death in all three groups, with a stronger correlation observed in the MAPT group (r=0·45 between individual and parental age at onset, r=0·63 between individual and mean family age at onset, r=0·58 between individual and parental age at death, and r=0·69 between individual and mean family age at death) than in either the C9orf72 group (r=0·32 individual and parental age at onset, r=0·36 individual and mean family age at onset, r=0·38 individual and parental age at death, and r=0·40 individual and mean family age at death) or the GRN group (r=0·22 individual and parental age at onset, r=0·18 individual and mean family age at onset, r=0·22 individual and parental age at death, and r=0·32 individual and mean family age at death). Modelling showed that the variability in age at onset and at death in the MAPT group was explained partly by the specific mutation (48%, 95% CI 35-62, for age at onset; 61%, 47-73, for age at death), and even more by family membership (66%, 56-75, for age at onset; 74%, 65-82, for age at death). In the GRN group, only 2% (0-10) of the variability of age at onset and 9% (3-21) of that of age of death was explained by the specific mutation, whereas 14% (9-22) of the variability of age at onset and 20% (12-30) of that of age at death was explained by family membership. In the C9orf72 group, family membership explained 17% (11-26) of the variability of age at onset and 19% (12-29) of that of age at death.Interpretation Our study showed that age at symptom onset and at death of people with genetic frontotemporal dementia is influenced by genetic group and, particularly for MAPT mutations, by the specific mutation carried and by family membership. Although estimation of age at onset will be an important factor in future pre-symptomatic therapeutic trials for all three genetic groups, our study suggests that data from other members of the family will be particularly helpful only for individuals with MAPT mutations. Further work in identifying both genetic and environmental factors that modify phenotype in all groups will be important to improve such estimates.Funding UK Medical Research Council, National Institute for Health Research, and Alzheimer's Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(19)30394-1

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1: Frequency of each of the three genetic groups by geographic location Countries with data included in the study are shown in dark blue (appendix p 20). Individual centres are shown as red dots on the map. Pie charts show relative frequency of each of the three genetic groups within a geographical area, with the number in the centre representing the number of cases included within that area.
Figure 1: Frequency of each of the three genetic groups by geographic location Countries with data included in the study are shown in dark blue (appendix p 20). Individual centres are shown as red dots on the map. Pie charts show relative frequency of each of the three genetic groups within a geographical area, with the number in the centre representing the number of cases included within that area.CC BY-NC-ND · PubMed Central
Figure 2: Violin plots of age at symptom onset and at death for the three genetic groups Data are median (bold lines) with IQR (dashed lines).
Figure 2: Violin plots of age at symptom onset and at death for the three genetic groups Data are median (bold lines) with IQR (dashed lines).CC BY-NC-ND · PubMed Central
Figure 3: Cumulative probability of symptom onset for each genetic group (A) and in the common GRN (B) and MAPT (C) mutations Data includes only individuals who have become symptomatic and does not account for family members who are not symptomatic.
Figure 3: Cumulative probability of symptom onset for each genetic group (A) and in the common GRN (B) and MAPT (C) mutations Data includes only individuals who have become symptomatic and does not account for family members who are not symptomatic.CC BY-NC-ND · PubMed Central
Figure 4: Correlation of individual age at symptom onset with parental (A) and mean familial (B) ages at symptom onset for GRN, MAPT, and C9orf72 genetic groups Pearson’s correlation coefficient is shown on each graph.
Figure 4: Correlation of individual age at symptom onset with parental (A) and mean familial (B) ages at symptom onset for GRN, MAPT, and C9orf72 genetic groups Pearson’s correlation coefficient is shown on each graph.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 313

Metadata

Authors
Moore, K. M., Nicholas, J., Grossman, M., McMillan, C. T., Irwin, D. J., Massimo, L., Van Deerlin, V. M., Warren, J. D., Fox, N. C., Rossor, M. N., Mead, S., Bocchetta, M., Boeve, B. F., Knopman, D. S., Graff-Radford, N. R., Forsberg, L. K., Rademakers, R., Wszolek, Z. K., van Swieten, J. C., Jiskoot, L. C., Meeter, L. H., Dopper, E. G., Papma, J. M., Snowden, J. S., Saxon, J., Jones, M., Pickering-Brown, S., Le Ber, I., Camuzat, A., Brice, A., Caroppo, P., Ghidoni, R., Pievani, M., Benussi, L., Binetti, G., Dickerson, B. C., Lucente, D., Krivensky, S., Graff, C., Öijerstedt, L., Fallström, M., Thonberg, H., Ghoshal, N., Morris, J. C., Borroni, B., Benussi, A., Padovani, A., Galimberti, D., Scarpini, E., Fumagalli, G. G., Mackenzie, I. R., Hsiung, G.-Y. R., Sengdy, P., Boxer, A. L., Rosen, H., Taylor, J. B., Synofzik, M., Wilke, C., Sulzer, P., Hodges, J. R., Halliday, G., Kwok, J., Sanchez-Valle, R., Lladó, A., Borrego-Ecija, S., Santana, I., Almeida, M. R., Tábuas-Pereira, M., Moreno, F., Barandiaran, M., Indakoetxea, B., Levin, J., Danek, A., Rowe, J. B., Cope, T. E., Otto, M., Anderl-Straub, S., de Mendonça, A., Maruta, C., Masellis, M., Black, S. E., Couratier, P., Lautrette, G., Huey, E. D., Sorbi, S., Nacmias, B., Laforce, R., Tremblay, M.-P. L., Vandenberghe, R., Damme, P. V., Rogalski, E. J., Weintraub, S., Gerhard, A., Onyike, C. U., Ducharme, S., Papageorgiou, S. G., Ng, A. S. L., Brodtmann, A., Finger, E., Guerreiro, R., Bras, J., Rohrer, J. D., Heller, C., Convery, R. S., Woollacott, I. O., Shafei, R. M., Graff-Radford, J., Jones, D. T., Dheel, C. M., Savica, R., Lapid, M. I., Baker, M., Fields, J. A., Gavrilova, R., Domoto-Reilly, K., Poos, J. M., Van der Ende, E. L., Panman, J. L., Donker Kaat, L., Seelaar, H., Richardson, A., Frisoni, G., Mega, A., Fostinelli, S., Chiang, H.-H., Alberici, A., Arighi, A., Fenoglio, C., Heuer, H., Miller, B., Karydas, A., Fong, J., João Leitão, M., Santiago, B., Duro, D., Ferreira, C., Gabilondo, A., De Arriba, M., Tainta, M., Zulaica, M., Ferreira, C., Semler, E., Ludolph, A., Landwehrmeyer, B., Volk, A. E., Miltenberger, G., Verdelho, A., Afonso, S., Tartaglia, M. C., Freedman, M., Rogaeva, E., Ferrari, C., Piaceri, I., Bessi, V., Lombardi, G., St-Onge, F., Doré, M.-C., Bruffaerts, R., Vandenbulcke, M., Van den Stock, J., Mesulam, M. M., Bigio, E., Koros, C., Papatriantafyllou, J., Kroupis, C., Stefanis, L., Shoesmith, C., Robertson, E., Coppola, G., Da Silva Ramos, E. M., & Geschwind, D.
Affiliations
  • UCL Queen Square Institute of Neurology (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Pennsylvania (US)
  • University College London (GB)
  • Mayo Clinic (US)
  • Mayo Clinic in Florida (US)
  • Erasmus MC (NL)
  • Salford Royal NHS Foundation Trust (GB)
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Centro San Giovanni di Dio Fatebenefratelli (IT)
  • Harvard University (US)
  • Karolinska University Hospital (SE)
  • Washington University in St. Louis (US)
  • University of Brescia (IT)
  • University of Milan (IT)
  • University of British Columbia (CA)
  • University of California, San Francisco (US)
  • German Center for Neurodegenerative Diseases (DE)
  • The University of Sydney (AU)
  • Hospital Clínic de Barcelona (ES)
  • Unidade Local de Saúde de Coimbra (PT)
  • Centro de Neurociências e Biologia Celular (PT)
  • Instituto de Salud Carlos III (ES)
  • Ludwig-Maximilians-Universität München (DE)
  • University of Cambridge (GB)
  • Universität Ulm (DE)
  • University of Lisbon (PT)
  • Sunnybrook Health Science Centre (CA)
  • Centre Hospitalier Universitaire de Limoges (FR)
  • Columbia University (US)
  • Don Carlo Gnocchi Foundation (IT)
  • University of Florence (IT)
  • Hôpital de l'Enfant-Jésus (CA)
  • Universitair Ziekenhuis Leuven (BE)
  • Northwestern University (US)
  • University of Manchester (GB)
  • Johns Hopkins University (US)
  • McGill University Health Centre (CA)
  • National and Kapodistrian University of Athens (GR)
  • National Neuroscience Institute (SG)
  • Florey Institute of Neuroscience and Mental Health (AU)
  • Western University (CA)
  • Van Andel Institute (US)
Corresponding author
Rohrer, Jonathan D
ORCID
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2020-02
Volume
19
Issue
2
Pages
145-156
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2993046104
Cited by
313
References
39
Citations by year
2026: 33 · 2025: 49 · 2024: 51 · 2023: 53 · 2022: 48 · 2021: 54 · 2020: 24
FWCI
21.28
Type
journal article
Language
en
Update notices
erratum (2020-02-01)
Open access
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, other-oa)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
  • Iris (University of Trento) (submittedVersion, cc-by-nc-nd)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • HAL (submittedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
  • Apollo
Funders
  • National Institute on Aging
  • Medical Research Council
  • National Institute of Neurological Disorders and Stroke
  • National Institute for Health and Care Research
  • Alzheimer's Drug Discovery Foundation
  • Association for Frontotemporal Degeneration
  • EU Joint Programme – Neurodegenerative Disease Research
  • Canadian Institutes of Health Research
  • National Institutes of Health
  • Ontario Ministry of Economic Development and Innovation
  • Novartis
  • Bundesministerium für Bildung und Forschung
  • Roche
  • Heart and Stroke Foundation of Canada
  • Stichting Dioraphte
  • Alzheimer's Society
  • Stockholm läns landsting
  • National Health and Medical Research Council
  • Eli Lilly and Company
  • Agence Nationale de la Recherche
  • Genentech
  • ZonMw
  • UCLH Biomedical Research Centre
  • UK Dementia Research Institute
  • Alzheimer's Disease Research Center, Emory University
  • Fédération pour la Recherche sur le Cerveau
  • GE Healthcare
  • Institut de France
  • Ministero della Salute
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Biogen
  • Hjärnfonden
  • AbbVie
  • Karolinska Institutet
  • Centre Hospitalier Universitaire de Nice
  • Fondation Roger de Spoelberch
  • Alzheimerfonden
  • Wellcome Trust
  • UCB
  • Janssen Pharmaceuticals
  • Ontario Brain Institute
  • Fondation Brain Canada
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
frontotemporal dementia, genetic frontotemporal dementia, age at symptom onset, age at death, disease duration, GRN mutations, MAPT mutations, C9orf72 repeat expansion, familial aggregation, family history (medicine), heritability, genotype-phenotype correlation
MeSH terms
C9orf72 Protein, Progranulins, Adult, Aged, Aged, 80 and over, Family, Female, Humans, Male, Middle Aged, Mutation, Phenotype, Retrospective Studies, Cohort Studies, tau Proteins, Age of Onset, Disease Progression, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. https://app.cochat.ai/papers/10.1016/s1474-4422(19)30394-1
The paper
Moore, K. M., Nicholas, J., Grossman, M., McMillan, C. T., Irwin, D. J., Massimo, L., Van Deerlin, V. M., Warren, J. D., Fox, N. C., Rossor, M. N., Mead, S., Bocchetta, M., Boeve, B. F., Knopman, D. S., Graff-Radford, N. R., Forsberg, L. K., Rademakers, R., Wszolek, Z. K., van Swieten, J. C., . . . Geschwind, D. (2020). Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(19)30394-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.